Clinic
Bay Area Healthcare Group, LTD.
Bay Area Healthcare Group, LTD. was paid $16.44M by Medicaid between Aug 2020 and Dec 2024, across 81 billing codes. Its largest line is 99284, emergency room visit (serious) — 50% of everything it billed.
33Billing provider infoBAY AREA HEALTHCARE GROUP, LTD.
CORPUS CHRISTI, TX 78412
CORPUS CHRISTI, TX 78412
33aNPI1508810573assigned 05/22/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$16.44M
24GClaims255,668
24DCodes billed81
24AFirst – last monthAug 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#29 of 320
Median peer was paid$205K
This provider vs. median80×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,535 | $209K | |
| 2021 | 44,020 | $2.83M | |
| 2022 | 68,298 | $4.42M | |
| 2023 | 97,427 | $5.93M | |
| 2024incomplete | 43,388 | $3.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 50% | 25,917 | 24,467 | $8.19M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 44,430 | 42,681 | $4.28M |
| 85027 | 2.5% | 29,746 | 27,772 | $413K | |
| G0410 | Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | 1.6% | 840 | 86 | $256K |
| 87400 | 1.5% | 6,730 | 6,400 | $254K | |
| 71045 | Radiologic examination, chest; single view | 1.5% | 7,169 | 6,782 | $253K |
| 80053 | Comprehensive metabolic panel | 1.4% | 11,867 | 11,033 | $223K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.0% | 684 | 112 | $170K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 6,719 | 6,304 | $166K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,284 | 8,785 | $158K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,067 | 4,904 | $152K |
| G0411 | Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | <1% | 457 | 53 | $152K |
69 more codes
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,687 | $143K |
| 93975 | <1% | 613 | $142K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 10,883 | $138K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,983 | $136K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,369 | $117K |
| 81001 | <1% | 14,437 | $106K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,017 | $96K |
| 87070 | <1% | 2,944 | $94K | |
| 76801 | <1% | 815 | $89K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,995 | $83K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,263 | $82K |
| 80076 | <1% | 2,525 | $78K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 362 | $56K |
| 84484 | <1% | 3,954 | $54K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 538 | $49K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 977 | $48K |
| 83690 | <1% | 4,552 | $41K | |
| 84702 | <1% | 1,842 | $31K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 953 | $31K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,593 | $27K |
| 99285 | Emergency room visit (most serious) | <1% | 362 | $26K |
| 81025 | <1% | 1,162 | $13K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 288 | $13K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 17 | $9K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 64 | $7K |
| 81003 | <1% | 1,650 | $6K | |
| 83735 | <1% | 1,028 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,816 | $5K |
| 87088 | <1% | 950 | $5K | |
| 83880 | <1% | 632 | $4K | |
| 84703 | <1% | 536 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 26 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 17 | $3K |
| 87040 | <1% | 1,040 | $3K | |
| 83605 | <1% | 895 | $3K | |
| 86901 | <1% | 935 | $2K | |
| 86900 | <1% | 935 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 25 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 47 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 97 | $1K |
| 84112 | <1% | 13 | $1K | |
| 82248 | <1% | 1,386 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 313 | $977.05 |
| 87077 | <1% | 187 | $802.29 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,488 | $704.70 |
| 85730 | <1% | 489 | $628.70 | |
| 85610 | <1% | 763 | $622.90 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 13 | $509.56 |
| 87186 | <1% | 189 | $369.84 | |
| 87800 | <1% | 16 | $366.80 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,190 | $356.00 |
| 86850 | <1% | 53 | $302.96 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 65 | $280.69 |
| 87420 | <1% | 12 | $265.98 | |
| 82550 | <1% | 150 | $257.14 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 25 | $254.08 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 15 | $172.44 |
| 85379 | <1% | 27 | $131.51 | |
| 82553 | <1% | 13 | $124.43 | |
| 87210 | <1% | 19 | $106.19 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 17 | $96.48 |
| 86140 | <1% | 28 | $62.44 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 59 | $43.09 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 783 | $39.13 |
| 84100 | <1% | 16 | $5.68 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $5.07 |
| A9270 | Non-covered item or service | 0% | 2,054 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 54 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 484 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNICOSIA, CHRIS (CFO)